Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAN 2020 | Opicapone in PD with motor fluctuations: post-hoc analysis of BIPARK-I and II

Georg Ebersbach, MD, Movement Disorders Clinic, Beelitz‐Heilstätten, Germany, discusses the efficacy and safety of opicapone in Parkinson’s disease patients according to the duration of motor fluctuations. In particular, Dr Ebersbach outlines the post-hoc analysis of the BIPARK-I and BIPARK-II trials. This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).